Verrica Holds Type A Meeting With FDA For Potential Approval Of Skin Infection Candidate
The U.S. Food and Drug Administration (FDA) convened a Type A meeting with Verrica Pharmaceuticals (NASDAQ: VRCA) regarding the course of action for the clearance of its drug candidate VP-102.
